These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16276082)

  • 1. Prevention of stroke in patients with diabetes mellitus and the metabolic syndrome.
    Rothwell PM
    Cerebrovasc Dis; 2005; 20 Suppl 1():24-34. PubMed ID: 16276082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary prevention of stroke with antiplatelet agents in patients with diabetes mellitus.
    Piechowski-Jozwiak B; Maulaz A; Bogousslavsky J
    Cerebrovasc Dis; 2005; 20 Suppl 1():15-23. PubMed ID: 16276081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study.
    Najarian RM; Sullivan LM; Kannel WB; Wilson PW; D'Agostino RB; Wolf PA
    Arch Intern Med; 2006 Jan; 166(1):106-11. PubMed ID: 16401818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
    Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
    J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic syndrome in type 2 diabetes: When does it matter?
    Wong J; Molyneaux L; Constantino MI; Twigg SM; Yue DK
    Diabetes Obes Metab; 2006 Nov; 8(6):690-7. PubMed ID: 17026494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in secondary stroke prevention: prevalence of multiple metabolic risk factors, including abnormal glycaemia, in ischaemic stroke and transient ischaemic attack.
    Scott DP; Greenfield JR; Bramah V; Alford J; Bennett C; Markus R; Campbell LV
    Intern Med J; 2010 Apr; 40(4):275-80. PubMed ID: 19383060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and treatment of metabolic syndrome in adolescents with type 2 diabetes.
    Sanders BH; Lubsch LM; West DS
    Ann Pharmacother; 2006 Sep; 40(9):1517-21. PubMed ID: 16896016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke prevention: management of modifiable vascular risk factors.
    Leys D; Deplanque D; Mounier-Vehier C; Mackowiak-Cordoliani MA; Lucas C; Bordet R
    J Neurol; 2002 May; 249(5):507-17. PubMed ID: 12021938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort.
    Athyros VG; Liberopoulos EN; Mikhailidis DP; Papageorgiou AA; Ganotakis ES; Tziomalos K; Kakafika AI; Karagiannis A; Lambropoulos S; Elisaf M
    Angiology; 2007 Dec-2008 Jan; 58(6):689-97. PubMed ID: 18216378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus and stroke.
    Idris I; Thomson GA; Sharma JC
    Int J Clin Pract; 2006 Jan; 60(1):48-56. PubMed ID: 16409428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and risk stratification of patients with the metabolic syndrome and diabetes.
    Wong ND
    Expert Rev Cardiovasc Ther; 2006 Mar; 4(2):181-90. PubMed ID: 16509814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of metabolic syndrome in type 2 diabetes and its relationship with insulin resistance.
    Ahmed S; Ahmed SA; Ali N
    J Ayub Med Coll Abbottabad; 2010; 22(1):22-7. PubMed ID: 21409896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type-2 diabetes mellitus related cardiovascular risk: new options for interventions to reduce risk and treatment goals.
    Hobbs FD
    Atheroscler Suppl; 2006 Aug; 7(4):29-32. PubMed ID: 16822723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stroke: acute treatments and secondary prevention].
    Leys D; Cordonnier C
    Med Sci (Paris); 2009; 25(8-9):733-8. PubMed ID: 19765388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thailand diabetes registry project: prevalence and risk factors of stroke in thai diabetic patients.
    Plengvidhya N; Leelawatana R; Pratipanawatr T; Deerochanawong C; Krittiyawong S; Bunnag P; Kosachunhanun N; Suwanwalaikorn S; Benjasuratwong Y; Chetthakul T; Ngarmukos C; Vannasaeng S; Mongkolsomlit S; Komoltri C; Rawdaree P
    J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S49-53. PubMed ID: 17715834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population.
    Mancia G; Bombelli M; Facchetti R; Madotto F; Corrao G; Trevano FQ; Giannattasio C; Grassi G; Sega R
    J Hypertens; 2008 Aug; 26(8):1602-11. PubMed ID: 18622239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.